AKR1B10 overexpression in breast cancer: Association with tumor size, lymph node metastasis and patient survival and its potential as a novel serum marker

Aldo-keto reductase family 1, member B10 is secreted through a lysosome-mediated non-classical pathway

(2011) Di-xian Luo et al.   BIOCHEMICAL JOURNAL

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Human aldo–keto reductases 1B1 and 1B10: A comparative study on their enzyme activity toward electrophilic carbonyl compounds

(2011) Yi Shen et al.   CHEMICO-BIOLOGICAL INTERACTIONS

AKR1B10 induces cell resistance to daunorubicin and idarubicin by reducing C13 ketonic group

(2011) Linlin Zhong et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

Systems Analysis of Protein Modification and Cellular Responses Induced by Electrophile Stress

(2010) Aaron T. Jacobs et al.   ACCOUNTS OF CHEMICAL RESEARCH

Aldo–keto reductase family 1 B10 protein detoxifies dietary and lipid-derived alpha, beta-unsaturated carbonyls at physiological levels

(2009) Linlin Zhong et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Serial determination of CEA and CA 15.3 in breast cancer follow-up: An assessment of their diagnostic accuracy for the detection of tumour recurrences

(2009) Luigi Mariani et al.   BIOMARKERS

Quantitative multiplexed analysis of ErbB family coexpression for primary breast cancer prognosis in a large retrospective cohort

(2009) Jennifer M. Giltnane et al.   CANCER

Molecular Mechanisms of 4-Hydroxy-2-nonenal and Acrolein Toxicity: Nucleophilic Targets and Adduct Formation

(2009) Richard M. LoPachin et al.   CHEMICAL RESEARCH IN TOXICOLOGY

Fibrates in the Chemical Action of Daunorubicin

(2009) Ganesaratnam Balendiran   CURRENT CANCER DRUG TARGETS

Aldo-keto Reductase Family 1 Member B10 Promotes Cell Survival by Regulating Lipid Synthesis and Eliminating Carbonyls

(2009) Chun Wang et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Therapeutic Strategies for Triple-Negative Breast Cancer

(2008) Antoinette R. Tan et al.   CANCER JOURNAL

Oxidation of PAHtrans-Dihydrodiols by Human Aldo-Keto Reductase AKR1B10

(2008) Amy M. Quinn et al.   CHEMICAL RESEARCH IN TOXICOLOGY

Role of human aldo–keto-reductase AKR1B10 in the protection against toxic aldehydes

(2008) Hans-Jörg Martin et al.   CHEMICO-BIOLOGICAL INTERACTIONS

Aldo-keto reductases from the AKR1B subfamily: Retinoid specificity and control of cellular retinoic acid levels

(2008) F. Xavier Ruiz et al.   CHEMICO-BIOLOGICAL INTERACTIONS

HER-2 and Topoisomerase II As Predictors of Response to Chemotherapy

(2008) Kathleen I. Pritchard et al.   JOURNAL OF CLINICAL ONCOLOGY

Relationship Between Quantitative Estrogen and Progesterone Receptor Expression and Human Epidermal Growth Factor Receptor 2 (HER-2) Status With Recurrence in the Arimidex, Tamoxifen, Alone or in Combination Trial

(2008) Mitch Dowsett et al.   JOURNAL OF CLINICAL ONCOLOGY

AKR1B10 in usual interstitial pneumonia: Expression in squamous metaplasia in association with smoking and lung cancer

(2008) Chih-Ping Li et al.   PATHOLOGY RESEARCH AND PRACTICE